ReproSil 4000 SEC

Size Exclusion Column for High-Molecular-Weight Polymers and Biopolymers

ReproSil 4000 SEC is a silica-based HPLC column developed for size exclusion chromatography (SEC) in the molecular weight range of 20,000 – 500,000 Da. With its optimized pore structure, the column allows efficient size-based separation of medium to large biomolecules and synthetic polymers while minimizing secondary interactions. The stationary phase provides excellent mechanical stability, reproducible retention, and sharp peak shapes, making it suitable for both analytical and preparative SEC workflows. ReproSil 4000 SEC is particularly well-suited for applications in biotechnology, pharmaceutical research, and polymer characterization.

ReproSil 4000 SEC combines optimized pore architecture with robust silica stability – the reliable choice for accurate and reproducible SEC separations in the 20,000–500,000 Da range.

Key Features:

  • Silica-based stationary phase optimized for size exclusion chromatography

  • Molecular weight separation range: 20,000 – 500,000 Da

  • Accurate size-based separation with minimal secondary interactions

  • High mechanical stability and reproducibility

  • Suitable for analytical and preparative applications

  • Manufactured and QC-tested by Dr. Maisch HPLC GmbH

  • Available in 5 µm

Typical Applications:

  • Separation and characterization of proteins and enzymes

  • Analysis of nucleic acids and large biomolecules

  • Molecular weight distribution studies of biopolymers and synthetic polymers

  • Pharmaceutical and biochemical research involving high-molecular-weight compounds

Specifications

Request Product
Particle Size
  • 5 µm
Pore Size 400 Å
Surface Area 120 m²/g
Phase/Modification PEG
Particle Type
Separation Mode
USP Code
Endcapping No
Carbonload 11 %
pH Range 2 to 8

Applications

Material Number

Phase Material Number
ReproSil 4000 SEC, 5 µm r45.sec.
ReproSil 300 SEC ReproSil 5000 SEC

Any questions?
We are here to help you.

info@dr-maisch.com +49 7073 5035 7

Follow us